Thyroid disease

Exposure to 'Forever Chemicals' Costs U.S. Billions in Health Costs

Retrieved on: 
Tuesday, July 26, 2022
Linda, Diabetes, Hazard ratio, PFAS, World, Environment, United Nations Environment Programme, Philadelphia, MPH, Water, United States Environmental Protection Agency, Center, American Academy, Houghton Mifflin Harcourt, High society, United Nations, Population health, Pesticide, Pediatrics (journal), Woman, Electronics, Endometriosis, Infertility, Research, National, Hypothyroidism, Travel, MPP, Footprint, World Health Organization, Uterus, Obesity, New York University Grossman School of Medicine, Cancer, Hospital, Endocrine Society, Pediatrics, Einstein Medical Center Philadelphia, Plastic, Pneumonia, MD, Blood, Department, NYU, National Health and Nutrition Examination Survey, Kidney, Investor, Thyroid disease, Population, Hormone, NYU Langone Health, Health insurance, Pharmaceutical industry, Medicine, Doctor of Philosophy, Health

The substances are believed to disrupt the function of hormones, signaling compounds that influence many bodily processes.

Key Points: 
  • The substances are believed to disrupt the function of hormones, signaling compounds that influence many bodily processes.
  • Together, the diseases generate medical bills and reduce worker productivity across a lifetime to create the costs measured by the study, say the study authors.
  • Previous investigations have quantified the medical burden and financial costs of low birth weight due to PFAS exposure.
  • However, the new study, publishing online July 26 in the journal Exposure and Health, incorporates a much broader range of health consequences across the lifespan, says Kahn.

GLOBAL DOWN SYNDROME FOUNDATION PUBLISHES FAMILY-FRIENDLY VERSION OF GLOBAL MEDICAL CARE GUIDELINES FOR ADULTS WITH DOWN SYNDROME

Retrieved on: 
Thursday, June 23, 2022
GLOBE, Patient, University, Adult, Diabetes, Color, Instagram, Behavior, National, American Medical Association, Down syndrome, Anschutz Medical Campus, CO, Cardiovascular disease, Osteoporosis, Thyroid disease, Guideline, Degenerative disease, Research, CEO, Social media, Sleep apnea, Dementia, Lymphatic system, Axis (anatomy), Prenatal testing, Congress, Obesity, Journal, Facebook, Dietary supplement, Pharmaceutical industry

Denver, CO, June 23, 2022 (GLOBE NEWSWIRE) -- Today, Global Down Syndrome Foundation (GLOBAL) announced the publication of a family-friendly version of the GLOBAL Medical Care Guidelines for Adults with Down Syndrome (GLOBAL Adult Guideline).

Key Points: 
  • Denver, CO, June 23, 2022 (GLOBE NEWSWIRE) -- Today, Global Down Syndrome Foundation (GLOBAL) announced the publication of a family-friendly version of the GLOBAL Medical Care Guidelines for Adults with Down Syndrome (GLOBAL Adult Guideline).
  • The Family-Friendly GLOBAL Adult Guideline has helpful pull-out quotes, large photos and font, and is color coded by medical topic.
  • To learn more about the GLOBAL Guideline, visit www.globaldownsyndrome.org/medical-care-guidelines-for-adults/
    To learn more about Global Down Syndrome Foundation, visit www.globaldownsyndrome.org
    The Global Down Syndrome Foundation (GLOBAL) is the largest non-profit in the U.S. working to save lives and dramatically improve health outcomes for people with Down syndrome.
  • GLOBALs widely circulated medical publications include Global Medical Care Guidelines for Adults with Down Syndrome , Prenatal Testing and Information about Down Syndrome , and the award-winning magazine Down Syndrome World TM .

Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June

Retrieved on: 
Wednesday, June 15, 2022
Degenerative disease, Technology, Regenerative medicine, Survival, Conditional sentence, Thyroid disease, Haemophilia, Thyroid, Protein, Immune system, University, Potency (pharmacology), Chicago (franchise), Partnership, Truist Financial, Patient, Cell, Type 1 diabetes, Real estate, Medical device, Pharmaceutical industry

If you are interested in arranging a 1x1 meeting request, please contact your Truist representative.

Key Points: 
  • If you are interested in arranging a 1x1 meeting request, please contact your Truist representative.
  • In May 2022, Sernova and Evotec entered into a global strategic partnership to develop an implantable off-the-shelf iPSC-based (induced pluripotent stem cells) beta cell replacement therapy.
  • This partnership provides Sernova an unlimited supply of insulin-producing cells to treat millions of patients with insulin-dependent diabetes (type 1 and type 2).
  • Sernova is also gearing up to be in the clinic in two additional programs that utilize its Cell Pouch System an implantable cell therapy for benign thyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral factor 8 gene therapy for hemophilia A.

Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022

Retrieved on: 
Monday, June 6, 2022
Survival, Therapy, Technology, PSH, Immune system, Transplant, Haemophilia, Regenerative medicine, Potency (pharmacology), Partnership, American Diabetes Association, IPSC, Hypoglycemia, CM, Trial of the century, Portal vein, Immunosuppression, Association, Blood, HU, Type 1 diabetes, Conditional sentence, Degenerative disease, Cell, ADA, University, Patient, Injection, JAMA, TSX, Incidence, Prevalence, Ernest, C-peptide, University of Chicago, Thyroid disease, FSE, Thyroid, BMC Medicine, Diabetes Care, Disease, Nasdaq, GLOBE, Insulin, Clinical trial, Economic cost, Principal, Chicago (franchise), Protein, Pharmaceutical industry, Medical device, Dietary supplement, T1D, Diabetes

We are encouraged by the data demonstrating our Cell Pouch System has been well tolerated and multiple patients remain insulin independent.

Key Points: 
  • We are encouraged by the data demonstrating our Cell Pouch System has been well tolerated and multiple patients remain insulin independent.
  • We remain on track to further dose the three aforementioned subjects and to implement the higher capacity Cell Pouch System in the next implanted patients.
  • Sernovas Cell Pouch System is designed to address this vastly expanding need by providing a functional cure for the millions of people afflicted by insulin-dependent diabetes worldwide.
  • This partnership provides Sernova an unlimited supply of insulin-producing cells to treat millions of patients with insulin-dependent diabetes (type 1 and type 2).

World Hypoparathyroidism Day - New Study Shows Surgeon Inexperience as #1 Cause of this Lifelong Condition

Retrieved on: 
Wednesday, June 1, 2022
Well, Life, Vitamin D, Thyroid cancer, Urination, Time, Thyroid disease, Anxiety, Parathyroid hormone, Nausea, Rest, IV, Fatigue, B cell, Depression, Parathyroid disease, CEO, Pain scale, Disease, PTH, Blood, Amnesia, Female, Center, The Center, Weakness, Hypoparathyroidism, Patient, Calcium, Incidence, Exocrine gland, Nervous system, Muscle, Surgeon, Hospital, Cancer, Dentistry, Pharmaceutical industry, Health insurance

TAMPA, Fla., June 1, 2022 /PRNewswire/ --The Norman Parathyroid Center recognizes World Hypoparathyroidism Day, June 1, by highlighting its number one cause surgeon inexperience.

Key Points: 
  • TAMPA, Fla., June 1, 2022 /PRNewswire/ --The Norman Parathyroid Center recognizes World Hypoparathyroidism Day, June 1, by highlighting its number one cause surgeon inexperience.
  • Hypoparathyroidism is a very rare condition in the general population where it can occur in mild to moderate forms due to genetic problems.
  • On World Hypoparathyroidism Day, it is important to understand that more than 95% of patients with hypoparathyroidism have this problem as a complication from thyroid or parathyroid surgery.
  • World Hypoparathyroidism Day reminds us that the key to reducing the incidence of hypoparathyroidism lies in the hands of the patients.

Global $1 Billion Anesthesia Disposables Markets, Analysis, & Forecasts 2016-2021, 2021-2026F, 2031F - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 26, 2022
Surgery, Health, Medtronic, EPA, Physician, Pain, Population, NJCAA National Football Championship, American Association of Nurse Anesthetists, Airway management, Press Uncuffed, AAMC, Respiratory disease, Patient, Thyroid disease, Association, Arthritis, Anesthesia, Pediatrics, UK, ETT, Teleflex, Child, Center, Health Education England, Doctor of Nursing Practice, Ageing, American Association, Oxygen, Growth, Mercury, Prevalence, Tidal volume, Anesthesiology, Cardiovascular disease, Nurse anesthetist, Dentistry, Medicine

The anesthesia disposables market consists of sales of anesthesia disposables and related services.

Key Points: 
  • The anesthesia disposables market consists of sales of anesthesia disposables and related services.
  • The anesthesia disposables are easy to use and portable devices.
  • The increase in the aging population leads to increased surgeries driving the anesthesia disposable market.
  • Global Anesthesia Disposables Forecast Market, 2021-2026F, 2031F, $ Billion

Clayman Thyroid Center Celebrates World Thyroid Day as the World's Leading Thyroid Surgery Destination

Retrieved on: 
Tuesday, May 24, 2022
Cancer, Medical tourism, Papillary thyroid cancer, Disease, Hospital, Survival, Endocrine surgery, Surgeon, Multimedia, Patient, Adrenal tumor, Thyroid disease, Health, Goitre, Thyroid cancer, Center, Neck, Pathology, Monroe Dunaway Anderson, Biopsy, Thyroid, Diagnosis, Marie Cassidy, Dentistry, Fireworks

As America's highest volume thyroid surgery center, and the leading destination for surgery for thyroid cancer world-wide, the Clayman Thyroid Center joins endocrinologists around the globe in educating the public on the role of the thyroid in their overall health.

Key Points: 
  • As America's highest volume thyroid surgery center, and the leading destination for surgery for thyroid cancer world-wide, the Clayman Thyroid Center joins endocrinologists around the globe in educating the public on the role of the thyroid in their overall health.
  • The Clayman Thyroid Center is a full-service thyroid surgery center, offering the most advanced forms of thyroid surgery for all types of thyroid tumors, from small thyroid nodules to large goiters and complex thyroid cancer.
  • Founded by Dr Gary Clayman, former Chief of Endocrine Surgery at MD Anderson, the Clayman Thyroid Center is widely known as America's leading thyroid surgery center performing nearly 2,000 thyroid operations annually.
  • About the Clayman Thyroid Center:
    Founded by one of the nation's best-known thyroid surgeons, the Clayman Thyroid Center is the highest volume thyroid cancer referral center in the United States.

Horizon Therapeutics plc Launches Letter-Writing Campaign to Empower Those Living with Thyroid Eye Disease (TED) to Confront the Condition Head On

Retrieved on: 
Wednesday, May 11, 2022
Mental Health, Health, General Health, Pharmaceutical, Optical, Biotechnology, Lazarus, The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure, Exophthalmos, Lists of World Heritage Sites, Instagram, Twitter, Nasdaq, Fibroblast, Autoimmunity, Courage, Red, Depression, Grave, Thyroid disease, Hypothyroidism, Patient, Mental Health Awareness Month, TED, Letter, Severe cognitive impairment, Family, Hyperthyroidism, Anxiety, Cell, Epidemiology, Television, Health, Conditional sentence, Quality of life, LinkedIn, Graves' ophthalmopathy, Disease, Friends, Science, Autoantibody, European Group, Diplopia, Inflammation, Walking, Strabismus, TED (conference), Paced Auditory Serial Addition Test, American, Risk, Multimedia, Pharmaceutical industry, Health insurance, Vaccine, Silviculture, Atlantic Ocean, Facebook, The New York Times

Living with a rare or chronic disease is a very personal experience that can sometimes feel isolating and overwhelming, said Gottlieb.

Key Points: 
  • Living with a rare or chronic disease is a very personal experience that can sometimes feel isolating and overwhelming, said Gottlieb.
  • My relationship with TED hasnt been easy, but because of what Ive been through, I take pride in everything Ive accomplished.
  • It is important to monitor eye symptoms and take weekly pictures to capture any changes in appearance.
  • Cockerham K, Stuertz N, Padnick-Silver L. Quality of Life Assessment of Chronic Thyroid Eye Disease (TED) Patients in the United States.

Global Endocrine Testing Market Analysis/Research Report 2022-2027: Tests to Measure Thyroid-Stimulating Hormone (TSH) are Expected to Influence Market Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
Health, Biotechnology, First Nations in Ontario, Triiodothyronine, Androgen deficiency, FT4, Thyroid disease, COVID-19, Roche, University Medical Center Groningen, Thyroid, Department, Geriatrics, ATA, American Thyroid Association, FT3, Incidence, Patient, UN, Tobacco, Growth, Risk, Laboratory, Abbott Laboratories, TT3, Growth hormone, Woman, Smoking, Groningen, CAGR, United Nations, Technology, Serum, Research, University of Groningen, Nephrology, Hypothyroidism, TSH, Menopause, University, Hyperthyroidism, Government, Disease, Endocrine system, Man, Medical device, Vaccine, Pharmaceutical industry, Agriculture

Globally, hormonal imbalances are increasing among individuals of all ages, which is driving the endocrine testing market.

Key Points: 
  • Globally, hormonal imbalances are increasing among individuals of all ages, which is driving the endocrine testing market.
  • Since endocrine testing tools are in high demand, market players are more committed to developing new products.
  • The demand for advanced endocrine testing technologies is also expected to grow due to diseases such as hypothyroidism and hyperthyroidism.
  • As a result, the rise in TSH testing is expected to boost market growth for the global endocrine testing market.

Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity

Retrieved on: 
Tuesday, April 19, 2022
NET, Pancreas, Nausea, Thyroid disease, Adult, Pharmacotherapy, Somatostatin, Rash, Neuroendocrine tumor, Radiopharmaceutical, B cell, GLOBE, Anaphylaxis, Patient, Itch, Neoplasm, Inflammation, Tissue, Lung, NETS, SSTR2, Heart, Copper, Radiation, Diagnosis, History, Wilms' tumor, Nuclear medicine, Angioedema, Marketing, Safety, Physician, Disease, Vomiting, Flushing, Risk, Liver, Gastrointestinal tract, Prostate, Cancer, PET, Pharmaceutical industry, Medical imaging, Birth control, Copper (64Cu) oxodotreotide

ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market.

Key Points: 
  • ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market.
  • We are incredibly pleased with the overwhelming response to Detectnet that has warranted an increase in production.
  • At Curium, we are focused on redefining the experience of cancer through our trusted legacy in nuclear medicine.
  • We are very pleased with this increase in commercial capacity and are excited Detectnet will be even more accessible.